145 related articles for article (PubMed ID: 35305430)
1. Production of positron-emitting radionuclide yttrium-86 with a computer-aided design target for positron emission tomography.
Chen J; Wang J; Xu M; Jia X; Song G; Liu Z
Nucl Med Biol; 2022; 108-109():54-60. PubMed ID: 35305430
[TBL] [Abstract][Full Text] [Related]
2. Automated processing of solid target
Dinh T; Panopoulos H; Poniger S; Scott AM
Appl Radiat Isot; 2022 Mar; 181():110052. PubMed ID: 35032841
[No Abstract] [Full Text] [Related]
3. Positron Emission Intensity in the Decay of
Uddin MS; Qaim SM; Scholten B; Basunia MS; Bernstein LA; Spahn I; Neumaier B
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164033
[TBL] [Abstract][Full Text] [Related]
4. Availability of yttrium-90 from strontium-90: a nuclear medicine perspective.
Chakravarty R; Dash A; Pillai MR
Cancer Biother Radiopharm; 2012 Dec; 27(10):621-41. PubMed ID: 23009585
[TBL] [Abstract][Full Text] [Related]
5. Taking cyclotron
Nelson BJB; Wilson J; Richter S; Duke MJM; Wuest M; Wuest F
Nucl Med Biol; 2020; 80-81():24-31. PubMed ID: 32004935
[TBL] [Abstract][Full Text] [Related]
6. Production of the next-generation positron nuclide zirconium-89 (
Wang F; Ding J; Guo X; Liu T; Ding L; Xia L; Zhu H; Yang Z
J Labelled Comp Radiopharm; 2021 Jan; 64(1):47-56. PubMed ID: 33067822
[TBL] [Abstract][Full Text] [Related]
7. 86Y based PET radiopharmaceuticals: radiochemistry and biological applications.
Nayak TK; Brechbiel MW
Med Chem; 2011 Sep; 7(5):380-8. PubMed ID: 21711222
[TBL] [Abstract][Full Text] [Related]
8. Monte Carlo simulation of PET and SPECT imaging of 90Y.
Takahashi A; Himuro K; Yamashita Y; Komiya I; Baba S; Sasaki M
Med Phys; 2015 Apr; 42(4):1926-35. PubMed ID: 25832083
[TBL] [Abstract][Full Text] [Related]
9. Target manufacturing by Spark Plasma Sintering for efficient
Cisternino S; Cazzola E; Skliarova H; Amico J; Malachini M; Gorgoni G; Anselmi-Tamburini U; Esposito J
Nucl Med Biol; 2022; 104-105():38-46. PubMed ID: 34856450
[TBL] [Abstract][Full Text] [Related]
10. Comparison of positron emission tomography and bremsstrahlung imaging to detect particle distribution in patients undergoing yttrium-90 radioembolization for large hepatocellular carcinomas or associated portal vein thrombosis.
Padia SA; Alessio A; Kwan SW; Lewis DH; Vaidya S; Minoshima S
J Vasc Interv Radiol; 2013 Aug; 24(8):1147-53. PubMed ID: 23792126
[TBL] [Abstract][Full Text] [Related]
11. Preparation of high specific activity (86)Y using a small biomedical cyclotron.
Yoo J; Tang L; Perkins TA; Rowland DJ; Laforest R; Lewis JS; Welch MJ
Nucl Med Biol; 2005 Nov; 32(8):891-7. PubMed ID: 16253815
[TBL] [Abstract][Full Text] [Related]
12. (86)Y production via (86)Sr(p,n) for PET imaging at a cyclotron.
Sadeghi M; Aboudzadeh M; Zali A; Zeinali B
Appl Radiat Isot; 2009; 67(7-8):1392-6. PubMed ID: 19285420
[TBL] [Abstract][Full Text] [Related]
13. Quantitative and Qualitative Improvement of Low-Count [
Seo Y; Khalighi MM; Wangerin KA; Deller TW; Wang YH; Jivan S; Kohi MP; Aggarwal R; Flavell RR; Behr SC; Evans MJ
Mol Imaging Biol; 2020 Feb; 22(1):208-216. PubMed ID: 30993558
[TBL] [Abstract][Full Text] [Related]
14. Radiochemical studies relevant to 86Y production via 86Sr(p,n)86Y for PET imaging.
Sadeghi M; Aboudzadeh M; Zali A; Mirzaii M; Bolourinovin F
Appl Radiat Isot; 2009 Jan; 67(1):7-10. PubMed ID: 18930657
[TBL] [Abstract][Full Text] [Related]
15. Optimized production of
Dellepiane G; Casolaro P; Gottstein A; Mateu I; Scampoli P; Braccini S
Appl Radiat Isot; 2023 May; 195():110737. PubMed ID: 36863264
[TBL] [Abstract][Full Text] [Related]
16. Production and separation of non-carrier-added 86Y from enriched 86Sr targets.
Avila-Rodriguez MA; Nye JA; Nickles RJ
Appl Radiat Isot; 2008 Jan; 66(1):9-13. PubMed ID: 17869530
[TBL] [Abstract][Full Text] [Related]
17. The production of [124I]iodine and [86Y]yttrium.
Schmitz J
Eur J Nucl Med Mol Imaging; 2011 May; 38 Suppl 1():S4-9. PubMed ID: 21484376
[TBL] [Abstract][Full Text] [Related]
18.
Le Fur M; Caravan P
Methods Enzymol; 2021; 651():313-342. PubMed ID: 33888208
[TBL] [Abstract][Full Text] [Related]
19. Electron- and positron-emitting radiolanthanides for therapy: aspects of dosimetry and production.
Uusijärvi H; Bernhardt P; Rösch F; Maecke HR; Forssell-Aronsson E
J Nucl Med; 2006 May; 47(5):807-14. PubMed ID: 16644751
[TBL] [Abstract][Full Text] [Related]
20. (89)Zr as a PET surrogate radioisotope for scouting biodistribution of the therapeutic radiometals (90)Y and (177)Lu in tumor-bearing nude mice after coupling to the internalizing antibody cetuximab.
Perk LR; Visser GW; Vosjan MJ; Stigter-van Walsum M; Tijink BM; Leemans CR; van Dongen GA
J Nucl Med; 2005 Nov; 46(11):1898-906. PubMed ID: 16269605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
